FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer
FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer
Recruiting · NCT04174352 · Registry updated 2026-07-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer | ERα+ Breast Cancer; ESR1 Gene Mutation | Recruiting | Early phase 1 | 2026-07-21 | NCT04174352 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Wisconsin, Madison | 265 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Wisconsin Carbone Cancer Center | Madison | United States | 58 |
| Wisconsin Oncology Network (WONIX) sites | Madison | United States | 1 |